Dr. Charles R. Farber's lab at the University of Virginia focuses on understanding the genetic factors that influence bone health and repair. By using mouse models, they are exploring how different genes affect bone regeneration and strength, which could lead to new treatments for conditions like osteoporosis. This research is particularly significant because bone repair is a major public health issue, with millions suffering from fractures and impaired healing each year.

Dr. Suna Onengut's lab at the University of Virginia studies type 1 diabetes (T1D), a complex autoimmune disorder. The research focuses on understanding how genetic risk factors influence the immune responses that lead to T1D, particularly through examining the interactions of immune cells and their gene expression. By utilizing advanced techniques like single-cell sequencing, the lab aims to identify biomarkers that could help predict the onset of T1D in genetically at-risk children.

Dr. John Platig's research lab focuses on understanding the role of RNA binding proteins in Chronic Obstructive Pulmonary Disease (COPD), a major global health concern. The lab investigates how these proteins regulate RNA molecules and how disruptions in their networks can affect disease outcomes. By utilizing cutting-edge genomic and proteomic techniques, the team aims to uncover COPD-specific regulatory changes and their implications for cellular function, contributing to a better understanding of this debilitating disease.

Dr. Stephen S. Rich's lab focuses on understanding how genetic factors contribute to Type 1 diabetes (T1D) through a process called alternative splicing. By analyzing blood samples and genetic data from children at risk of T1D, the lab aims to uncover how different genes and their variants can influence the immune response and lead to diabetes. This research has important implications for early diagnosis and potential therapies for T1D.